Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Neurotoxicity Syndrome, Cassava
Total 0 results
Nothing found
Sponsors and Collaborators
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Hospital ASEPEYO Sant Cugat
Eurofins Genoma
Aptis Medical
Apollo Neuroscience, Inc.
iCAD
Mª Victoria Maestre Sanchez
GFI
Agency for Science, Technology and Research
Korean Society of Spine Surgery
ASST Cremona, Cremona
Neurophth Therapeutics Inc
Alma Lasers Inc.
RMIT University, Melbourne, Australia
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Nacuity Pharmaceuticals, Inc.
Everett Meyer
Kupfer, David J., M.D.
Hospital Durand, Argentina
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
View Full List
Medical Conditions
The Strength Properties of the Aorta in Vitro
Dienogest
Luteal Phase Support
Recurrent Clear Cell Sarcoma of Soft Tissue
Disorder of Fluid Balance
Metachronous Adenoma
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Scleredema
Treatment Decisions
Chronic Constipation Symptoms
Fever
RISS Stage III Plasma Cell Myeloma
Gastric Cancer Stage IIIB-IIIC
Major Liver Surgery
Corneal Cross-Linking
Rheumatoid Arthritis(RA)
Splenic Trauma
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
T-LGL Leukemia
Immune-Mediated Inflammatory Disease
View Full List
Drug Interventions
THC
Intravenous deferiprone
Camptosar
GLPG1837 multiple ascending doses
Midazolam
TPN-101
Desvenlafaxine
Anticholinergic
PD-1/PD-L1 inhibitor
OnabotulinumtoxinA
MLN2480
Capecitabine and IMRT (if randomized to this arm)
Standard of care (SOC) for COVID-19
Olopatadine
Oxycodone/acetaminophen 5/325 mg
Intravenous Formulation of PD-0332991
Letrozole
RDX227675
Capecitabine/cisplatin
Fospropofol disodium, propofol
View Full List
CROs by country
Contract Research Organizations in Belgium
Contract Research Organizations in Cameroon
Contract Research Organizations in Colombia
Contract Research Organizations in Gambia
Contract Research Organizations in Georgia
Contract Research Organizations in Kenya
Contract Research Organizations in Latvia
Contract Research Organizations in New Zealand
Contract Research Organizations in Panama
Contract Research Organizations in Portugal
Contract Research Organizations in Russia
Contract Research Organizations in Slovenia
Contract Research Organizations in Sweden
CRO list by country
CROs in Rwanda
ACROSS Global
All CROs in Rwanda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe